I've invested in biotech for 25 years and have never seen a stock like EPCT, that has very promising drugs in human clinical trials, that has traded at 1 and change. EPCT has a very promising drug licensed to Myriad that is about to go into multiple PII trials and a very promising small molecule cancer drug in PI trials. This is without even considering Celpene and LidoPAIN in the equation. I bought 100,000 of the shares traded today and will not sell until I see at least 10. Stick around for the ride, because it will soon be fast and furious.
absolutely, the pipeline is impressive, just missing some exposure with some institutions starting coverage, as per my last discussion with the company they are working on this issue, good news are around the corner with this large pipeline, patience will be paid here. jmo and glta
Pipeline impressive???? Where have you found this? Go and look on their website http://www.epicept.com and you will find (1) drug in Phase II and (1) in Phase I!! This is not impressive at all even not for a 44 Mio company!